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Abstract
Purpose—A FRAX® model been recently calibrated for Kuwait, but guidance is needed on how 
to utilise fracture probabilities in the assessment and treatment of patients.
Methods—We compared age-specific fracture probabilities, equivalent to women with no clinical 
risk factors and a prior fragility fracture (without BMD), with the age-specific fracture 
probabilities associated with femoral neck T-scores of -2.5 SD and -1.5 SD, in line with current 
guidelines in Kuwait. Upper and lower assessment thresholds for BMD testing were additionally 
explored using FRAX.
Results—When a BMD T-score of -2.5 SD was used as an intervention threshold, FRAX 
probabilities of a major osteoporotic fracture in women aged 50 years were approximately two-
fold higher than in women of the same age but with an average BMD. The increase in risk 
associated with the BMD threshold decreased progressively with age such that, at the age of 83 
years or more, a T-score of -2.5 SD was associated with a lower probability of fracture than that of 
the age-matched general population with no clinical risk factors. The same phenomenon was 
observed from the age of 66 years at aT-score of -1.5 SD. A FRAX-based intervention threshold, 
defined as the 10-year probability of a major osteoporotic fracture in a woman of average BMI 
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with a previous fracture, rose with age from 4.3% at the age of 50 years to 23%, at the age of 90 
years, and identified women at increased risk at all ages. Qualitatively comparable findings were 
observed in the case of hip fracture probability and in men.
Conclusion—Intervention thresholds based on BMD alone do not optimally target women at 
higher fracture risk than age-matched individuals without clinical risk factors, particularly in the 
elderly. In contrast, intervention thresholds based on fracture probabilities equivalent to a ‘ fracture 
threshold’  consistently target women at higher fracture risk, irrespective of age.
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Introduction
Osteoporosis is operationally defined based on the measurement of bone mineral density 
(BMD) assessment [1], with recent refinements of the description that focus on 
measurements at the femoral neck as a reference standard [2]. The WHO-defined T-score of 
≤-2.5 SD, originally designed as an epidemiological tool, has been widely adopted as both a 
diagnostic and intervention threshold. The principal difficulty for fracture risk assessment is 
that this threshold has high specificity but low sensitivity, so that the majority of fragility 
fractures occur in individuals with BMD values above the osteoporosis threshold [3]. Over 
the last two decades, many risk factors have been identified that contribute to fracture risk, at 
least partly if not wholly independent of BMD: these include age, sex, a prior fracture [4], a 
family history of fracture [5], and lifestyle risk factors such as physical inactivity [6] and 
smoking [7]. These and other factors have been combined in analyses of individual cohort 
studies to develop algorithms and scores to characterise future risk in an individual.
The most widely validated and utilised fracture risk assessment tool is FRAX® which was 
developed by the former WHO Collaborating Centre at the University of Sheffield. The 
FRAX tool integrates the risks of fracture together with the risk of death to provide the ten-
year probability of hip fracture and major osteoporotic fracture (clinical spine, distal 
forearm, proximal humerus and hip fracture) [8, 9].
The 10-year probabilities of fracture [10] and death vary markedly in different regions of the 
world, so that the FRAX models are calibrated to the known epidemiology of fracture and 
death. This assumes that the relative importance of the risk factors and their interactions are 
the same as in the original material. At present, 63 country models are available, and the tool 
currently provides coverage for over 80% of the global population [11].
Historically, treatment has been targeted to patients with a prior fragility fracture, a WHO-
defined T-score or both. Since its release, FRAX has been incorporated into more than 100 
guidelines worldwide [12]. The setting of universal intervention thresholds is problematic 
from an international perspective since the risk of fracture, the costs of fracture and 
treatment, reimbursement policy and willingness to pay, vary in different countries. In 
Kuwait, assessment guidelines are predominantly based on BMD and the presence of 
osteoporosis. A FRAX model for Kuwait, calibrated to the total Kuwaiti population, was 
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released in March, 2016 [13]. The aim of the present analysis was to explore FRAX-based 
intervention thresholds that might be used to identify men age 50 years or more and 
postmenopausal women from Kuwait at high fracture risk and to compare this strategy with 
the selection of individuals based on BMD.
Methods
Guidelines in Kuwait
The Kuwait Osteoporosis Society, adopted BMD-based criteria as intervention thresholds in 
2014 [14]. The strategy was based on case-finding where men and women with one or more 
major risk factor (including fragility fracture after age 40 years, parental hip fracture, 
systemic glucocorticoid therapy, malabsorption, primary hyperparathyroidism, 
hypogonadism and osteopenia apparent on X-ray) or two or more minor risk factors are 
referred for densitometry. The currently published criterion for treatment of osteoporosis in 
Kuwait is a BMD T-score ≤−2.5 SD, though provision is made for treatment in patients with 
osteopenia using fixed FRAX probability thresholds of 20% for a major fracture and 3% for 
hip fracture. The guideline takes some elements from the guidelines of the National 
Osteoporosis Foundation in the US and those of the Scottish Intercollegiate Network in 
Scotland [15, 16].
FRAX based intervention threshold
The UK guidance for the identification of individuals at high fracture risk, first developed by 
the National Osteoporosis Guideline Group (NOGG), recommends that postmenopausal 
women with a prior fragility fracture may be considered for intervention without the 
necessity for a BMD test [17, 18]. In postmenopausal women without a fragility fracture but 
a FRAX risk factor, the intervention threshold set by NOGG is at the age-specific fracture 
probability equivalent to women with a prior fragility fracture. In this context, fragility 
fracture is defined as a previous fracture in adult life occurring spontaneously, or a fracture 
arising from trauma which, in a healthy individual, would not have resulted in a fracture 
(http://www.shef.ac.uk/FRAX/). For example, using the NOGG guidance, a woman at age 
65 years (BMI 24kg/m2) with a prior fragility fracture has a 10-year probability of a major 
osteoporotic fracture of 17% and this forms the intervention threshold for that age. A woman 
of the same age with no prior fracture but on glucocorticoids for rheumatoid arthritis has a 
fracture probability of 19%. Thus, the latter would be eligible for treatment despite the 
absence of a prior fracture. The same intervention threshold (17%) is applied to men of the 
same age, since the effectiveness and cost-effectiveness of intervention in men is broadly 
similar to that in women for equivalent risk. This approach was used to compare with the 
Kuwaiti guidance.
Comparison
Using the FRAX model for Kuwait we computed the 10-year probability of a major 
osteoporotic fracture and a hip fracture in men and women with a BMD T-score of -2.5 SD 
at 5 year intervals from the age of 50 years. We similarly computed the 10-year probability 
of a major osteoporotic fracture and a hip fracture with a BMD T-score of -1.5 SD. The T-
score of -1.5 SD was chosen to represent the mid-range of osteopenia. For comparison, 
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fracture probabilities were computed (without the inclusion of BMD) in women by age who 
had sustained a prior fragility fracture. Fracture probabilities by age were compared to age-
specific probabilities in men and women with no clinical risk factors (without the inclusion 
of BMD). Body mass index was set at 30kg/m2 (the average value Kuwaiti women [19]) for 
all scenarios and individuals were assumed to have no other FRAX risk variables.
In line with NOGG, we explored the setting of assessment thresholds for BMD. The 
inclusion of BMD in the calculation of probability improves the accuracy of the assessment 
[20] but its added value is greatest where fracture probabilities lie close to an intervention 
threshold [21–23]. In other words, testing is confined to those in whom there is a reasonable 
likelihood that individuals at high (or low) risk would be reclassified at low (or high) risk 
based on the BMD test. On this basis, we calculated two assessment thresholds which were 
applied to the FRAX-based thresholds described above:
The threshold probability below which neither treatment nor a BMD test should be 
considered (lower assessment threshold).
The threshold probability above which treatment may be recommended without the 
need for BMD (upper assessment threshold).
The lower assessment threshold was based on the 10-year probability (without BMD) of a 
major osteoporosis fracture equivalent to women without clinical risk factors (and a body 
mass index of 30 kg/m2). This is consistent with a view in most practice guidelines that 
individuals without clinical risk factors should not be considered eligible for assessment 
[12].
The upper assessment threshold was set to optimize the requirement for BMD testing [17]. 
As noted above, the risk of changing category from high risk to low risk or vice versa when 
adding BMD to the estimation of fracture probability is highest close to the threshold. When 
patients have a fracture probability that is 20% or more than the intervention threshold, 
almost no individuals are reclassified when probabilities are recomputed with the addition of 
BMD to FRAX [17]. For this reason, the upper assessment threshold was set at 1.2 times the 
intervention threshold. In some countries, assessment thresholds are based on hip fracture 
probabilities in addition to probabilities off a major osteoporotic fracture. The methodology 
used in the present report for hip fracture was identical to that used for a major osteoporotic 
fracture.
Results
In women with no clinical risk factors and an average BMD for age, probability of a major 
osteoporotic fracture rose with age from 1.0% at the age of 40 years to 14% at the age of 90 
years (Table 1). Equivalent hip fracture probabilities are given in supplementary information 
(Table A1).
Intervention thresholds based on BMD
In women age 50 years at the threshold of osteoporosis (a BMD T-score of -2.5 SD), fracture 
probability was more than two-fold higher than in women of the same age without any risk 
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factors. The 10-year fracture probability rose progressively with age from 2.6% at the age of 
40 years to 13% at the age of 90 years. With advancing years, the difference in probability 
between women with a T-score of -2.5 SD and women of the same age without any risk 
factors decreased. Above the age of 83 years, the fracture probability was lower than in 
women of the same age but with no risk factors (Figure 1). Thus, the BMD criterion for 
intervention using a fixed T-score became less and less appropriate with advancing age. At a 
T-score of -1.5 SD, the fracture probability was lower than in women of the same age but 
with no risk factors from the age of 66 years.
The fracture probabilities equivalent to women with a previous fragility fracture are shown 
in Table 1. The probability of a major osteoporotic fracture rose with age, from 2.3% at the 
age of 40 years to 23%, at the age of 90 years. Fracture probabilities were consistently 
higher than in women with no clinical risk factors.
When hip fracture probability was used, the risk of hip fracture was 9-fold increased at the 
age of 50 years for women with T-score -2.5 compared to women with no clinical risk 
factors and average BMD (albeit with low absolute probabilities in either scenario) and, as in 
the case of major osteoporotic fracture, decreased progressively with age. The fracture 
probability was lower than in women of the same age but with no risk factors from the age 
of 87 years (Figure 2). For a T-score of -1.5 SD, the same phenomenon was observed for hip 
fracture from the age of 65 years (data not shown).
In the case of men, the findings were similar. For a major osteoporotic fracture, a T-score of 
-2.5 SD was associated with a fracture probability that was lower than in men of the same 
age but with no risk factors from the age of 90 years and for a T-score of -1.5 SD, at or 
above the age of 80 years. When hip fracture probability was used, the same phenomena at a 
T-score of -2.5 SD in men noted at or above the age of 88 years (see Figure 2) and, with a T-
score of -1.5 SD, above the age of 78 years.
Probability-based intervention thresholds and BMD assessment thresholds
The intervention threshold was set at the age-dependent 10-year probability of a major 
osteoporotic fracture that was equivalent to a woman with a prior fragility fracture (see 
Figure 1). As used in the NOGG guidance, the lower assessment threshold, below which 
BMD tests are of limited value, was set at the age-specific probabilities in women with no 
clinical risk factors. The upper assessment was set at 1.2 times the intervention threshold. 
The three thresholds are shown in table 2. Intervention thresholds, based on hip fracture 
probability are shown in the supplementary appendix (Table A2). The practical applications 
of these thresholds for Kuwait are provided in the discussion below.
Discussion
Bone mineral density (BMD) measured by dual X-ray absorptiometry (DXA) is the current 
reference standard for the diagnosis of osteoporosis. Since BMD is one of the strongest 
predictors of fracture risk [24, 25], many agencies worldwide have adopted BMD-based 
criteria as intervention thresholds. The present study demonstrates weaknesses in the use of 
fixed BMD thresholds as intervention thresholds. Whereas a T-score threshold of -2.5 SD 
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was a strong risk factor for fracture at younger ages, with advancing age, the association 
with high risk decreased progressively with age. The effect was even more marked at a less 
stringent T-score threshold. For example, a T-score of -1.5 SD was a “protective factor” for 
hip fracture from the age of 65 years in that fracture probabilities were lower than in women 
in the ‘ general’  population (i.e. women with no clinical risk factors and average BMD for 
age). The reason relates to the decreasing BMD in the general population with age. The 
phenomenon has been noted in the case of major osteoporotic fractures in women from the 
Romania, UK and US [26– 27]. The present analysis identifies that the same phenomenon 
holds true for hip fracture prediction and in men.
In the context of the current guidelines in Kuwait, several additional factors make the use of 
the T-score problematic as the major gateway to targeting individuals at high fracture risk. 
Whereas a prior fragility fracture confers a risk that is significant at all ages and independent 
of BMD, this increase in risk is ignored in that treatment is recommended only where the 
BMD T-score ≤ -2.5 SD. The same is true for all major risk factors. Thus, the guideline does 
not use the information provided by the presence of strong risk factors. Bizarre but not 
improbable scenarios arise. For example, consider a 65-year old woman (BMI set at 30 
kg/m2) whose mother had sustained a hip fracture (Table 3). Under existing guidelines her 
risk factor earns her a BMD test and the decision to treat rests solely on her T-score. At a T-
score of -2.5 SD, the threshold of osteoporosis, she can be offered treatment (equivalent to a 
10-year probability of a major osteoporotic fracture of 11 %) but is denied treatment with a 
T-score of -2.0 SD, even though her fracture probability is higher than the BMD-based 
threshold (9.1 vs. 6.5 %).
A final consideration concerns the availability of densitometers in many countries. The 
policy assumes that all prospective patients should have a BMD test and the availability of 
BMD equipment is limited. In a recent survey, there were 7.5 DXA machines per million of 
the general Kuwaiti population (JA Kanis 2014 personal communication), whereas 11 or 
more is considered appropriate to service the needs of a case-finding strategy [29].
The advent of FRAX has provided an opportunity to base intervention thresholds based on 
fracture probability, which increases the sensitivity of fracture prediction compared to the 
use of BMD alone [20]. FRAX has been incorporated into more than 100 guidelines 
worldwide, but the way FRAX is used to identify cases for treatment varies. An increasing 
number of guidance documents have recommended the use of intervention thresholds that 
are based on age-specific fracture probabilities equivalent to a woman with a prior fragility 
fracture [30, 31], first espoused by the National Osteoporosis Guideline group (NOGG) in 
the UK [18]. In the present paper, we have compared the performance of the NOGG 
approach applied to the Kuwaiti population using the Kuwait specific FRAX model. The 
intervention threshold using this approach varied from 4.3 % at the age of 50 years to 23 % 
at the age of 90 years. Thus, men and women who have a fracture probability that is equal or 
exceeds that of a woman with a prior fracture would be eligible for treatment even in the 
absence of a fracture history. These intervention thresholds are developed without the use of 
BMD in the FRAX model. Notwithstanding, the categorisation of patients at high or low risk 
is improved using BMD. For this reason, the present study provided assessment thresholds 
for the use of BMD tests in a manner similar to that of NOGG. The approach capitalises on 
Johansson et al. Page 6
Osteoporos Int. Author manuscript; available in PMC 2018 April 03.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
the improved risk assessment provided by BMD tests but decreases the number of tests 
required when BMD is used as the principal gateway for assessment [32].
Practical application
The concept of assessment thresholds can be illustrated in terms of the management 
pathway. The management process begins with the assessment of fracture probability and 
the categorisation of fracture risk on the basis of age, sex, BMI and the clinical risk factors. 
On this information alone, some patients at high risk may be offered treatment without 
recourse to BMD testing. For example, as noted above, most guidelines in Europe and North 
America recommend treatment in the absence of BMD in women with a previous fragility 
fracture. Many would perform a BMD test, but frequently this is for reasons other than to 
decide on intervention (e.g. as a baseline for monitoring treatment). There will be other 
instances where the probability will be so low that a decision not to treat can be made 
without BMD. An example might be the well woman at menopause with no clinical risk 
factors. Thus, not all individuals require a BMD test.
The use of assessment thresholds is illustrated in the management algorithm given in Figure 
3 and outlined below [30].
1. Women with a prior fragility fracture should be considered for treatment.
2. Postmenopausal men and women with a clinical risk factor should have fracture 
probability assessed using the FRAX tool without measurement of BMD.
3. Individuals with probabilities of a major osteoporotic fracture below the lower 
assessment threshold given in Figure 3 can be reassured. A further assessment 
may be recommended in 5 years or less depending on the clinical context.
4. Men and women with probabilities of a major osteoporotic fracture above the 
upper assessment threshold (or with probabilities of a hip fracture above the 
upper limit) can be considered for treatment without BMD testing.
5. Individuals with probabilities of a major osteoporotic fracture within the limits of 
the assessment thresholds given in Figure 3 should have a BMD test and 
probabilities recomputed. If probabilities exceed the treatment threshold, 
intervention should be considered.
The intervention thresholds proposed above are not without limitations. The consequences 
of assessment and intervention thresholds on the requirements for BMD testing have not 
been explored. It will also be important to explore the cost-effectiveness of intervention and 
the budget impact of any changes in reimbursement policy. Despite these gaps, intervention 
strategies based on fracture probabilities are more effective than strategies reliant on the use 
of BMD alone in identifying high risk individuals for treatment and avoiding intervention in 
those at low risk. An added advantage is that BMD testing is not a prerequisite for 
assessment or treatment. This feature would be particularly useful in areas of Kuwait with 
limited access to DXA. It should be noted that the algorithms proposed are specific for 
Kuwait but the same principles can be applied to any country where a FRAX model is 
available. More generally, the mean BMI in Kuwaiti women is 30kg/m2 which will have an 
impact in lowering the treatment threshold compared with many countries. More 
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importantly, the thresholds derived depend critically on the hazards of fracture and death in 
Kuwait. Thus, each FRAX model is country specific. Notwithstanding, these factors do not 
nullify the general conclusion that age-dependent FRAX-based intervention thresholds 
identify women at higher fracture probability than fixed T-score thresholds.
We conclude that FRAX-based intervention thresholds identify men and women at higher 
fracture probability than fixed T-score thresholds, particularly in the elderly.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Summary
Many current guidelines for the assessment of osteoporosis, including those in Kuwait, 
initiate fracture risk assessment in men and women using BMD T-score thresholds. We 
compared the Kuwaiti guidelines with FRAX-based age-dependent intervention 
thresholds equivalent to that in women with a prior fragility fracture. FRAX-based 
intervention thresholds identified women at higher fracture probability than fixed T-score 
thresholds, particularly in the elderly.
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Fig. 1. 
10-year probabilities (%) of a major osteoporotic fracture for women from Kuwait at a T-
score of -2.5 SD (open triangle), -1.5 SD (open square) and prior fracture (open diamond). 
The shaded area represents fracture probabilities in women with no clinical risk factors and 
average BMD.
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Fig. 2. 
The 10-year probability of fracture in men and women with a T-score equal to -2.5 SD 
divided by the age-specific probability in individuals with no clinical risk factors and an 
average BMD for age. The horizontal line denotes a probability ratio of 1.0. MOF; major 
osteoporotic fracture.
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Fig. 3. 
Intervention thresholds for Kuwait as set by FRAX-based 10-year probabilities (%) of a 
major osteoporotic fracture. The red area is where treatment could be recommended, the 
green area is where treatment would not be recommended and the orange area is where 
BMD could be measured (where available) to enhance the estimation of fracture risk. UAT, 
upper assessment threshold; IT, intervention threshold; LAT, lower assessment threshold
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Table 1
10-year probabilities of a major fracture (hip, clinical spine, humerus and forearm) with the FRAX model for 
Kuwait for women. BMI set to 30kg/m2.
Age (years)
40 45 50 55 60 65 70 75 80 85 90
Major fracture
No clinical risk factors 1.0 1.4 2.0 2.5 3.1 3.8 4.7 6.2 8.5 12 14
BMD T-Score -2.5 SDa 2.6 3.3 4.3 5.3 6.0 6.5 7.1 8.0 9.5 11 13
Previous fracturea 2.3 3.2 4.3 5.4 6.5 7.6 9.0 11 14 19 23
BMD T-Score -1.5 SDa 1.6 2.1 2.8 3.3 3.7 4.0 4.4 5.2 6.4 7.9 9.2
Ratios between probabilities
T-score -2.5 vs. No CRF 2.6 2.4 2.2 2.1 1.9 1.7 1.5 1.3 1.1 0.9 0.9
Previous fracture vs. No CRF 2.3 2.3 2.2 2.2 2.1 2.0 1.9 1.8 1.6 1.6 1.6
T-score -1.5 vs. No CRF 1.6 1.5 1.4 1.3 1.2 1.1 0.9 0.8 0.8 0.7 0.7
aNo other clinical risk factors
CRF, clinical risk factors
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Table 2
Ten-year probabilities of a major osteoporotic fracture (%) in postmenopausal women by age to show the 
intervention threshold together with the upper assessment threshold and lower assessment threshold, derived 
using the Kuwaiti FRAX model. Under this scheme, BMD testing would be recommended at probabilities 
lying between the upper and lower assessment thresholds.
Age (years) Intervention threshold Lower assessment threshold Upper assessment threshold
40 2.3 1.0 2.8
45 3.2 1.4 3.8
50 4.3 2.0 5.1
55 5.4 2.5 6.5
60 6.5 3.1 7.8
65 7.6 3.8 9.1
70 9.0 4.7 11
75 11 6.2 13
80 14 8.5 17
85 19 12 23
90 23 14 27
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Table 3
Ten-year probability of a major osteoporotic fracture (%) in women age 65 years from Kuwait (BMI set to 30 
kg/m2) for different clinical scenarios.
Scenario BMD T--score CRF Fracture probability (%)
A -2.5 None 6.5
B -2.5 Parental history of hip fracture 11.0
C -2.0 None 5.0
D -2.0 Parental history of hip fracture 9.1
E No BMD Prior fracture 7.6
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